Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2022

Apr 14, 2022

SELL
$1.83 - $4.48 $2,562 - $6,272
-1,400 Closed
0 $0
Q4 2021

Jan 18, 2022

BUY
$2.35 - $5.58 $3,290 - $7,812
1,400 New
1,400 $0
Q3 2020

Oct 27, 2020

SELL
$3.7 - $5.47 $740 - $1,094
-200 Closed
0 $0
Q2 2020

Jul 22, 2020

BUY
$4.59 - $8.96 $918 - $1,792
200 New
200 $0

Others Institutions Holding IFRX

About InflaRx N.V.


  • Ticker IFRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 44,203,800
  • Market Cap $99M
  • Description
  • InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a nov...
More about IFRX
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.